ITRI.NASDAQItron, INC

Form 4: Itron Director Timothy Leyden Receives Stock Grant

Sentiment:

Insider Transaction Report


Itron, Inc. Director Timothy M. Leyden was granted 163 shares of common stock as part of his annual board compensation, with 61 shares deferred.

Summary

  • Timothy M. Leyden, a Director of Itron, Inc. (ITRI), acquired 163 shares of common stock.
  • The transaction occurred on October 1, 2025.
  • These shares were granted as part of his annual compensation for board service.
  • Mr. Leyden deferred the receipt of 61 shares, pursuant to Itron's Executive Deferred Compensation Plan.
  • Following this transaction, Mr. Leyden directly beneficially owns 15,553 shares of Itron common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director as part of their compensation, which is a standard practice aligning director interests with shareholders. It does not contain any unexpected positive or negative news.

Positives

  • The grant of common stock to Director Timothy M. Leyden aligns his interests with those of shareholders.
  • The transaction reflects a standard component of compensation for independent board members, indicating stable corporate governance practices.

Negatives

  • No negative aspects are identified in this routine insider transaction filing.

Risks

  • This Form 4 filing does not disclose specific risks.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

  • Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service.
  • Mr. Leyden deferred receipt of 61 shares pursuant to Itron's Executive Deferred Compensation Plan.

Industry Context

The grant of equity as part of director compensation is a common practice across various industries, including the technology and utility solutions sector where Itron operates. This method is widely used to align the interests of board members with those of shareholders, encouraging long-term value creation.

Comparison to Industry Standards

  • The practice of compensating independent directors with equity, such as common stock grants, is a well-established corporate governance standard.
  • While specific grant sizes vary by company size, industry, and board responsibilities, the mechanism itself is consistent with compensation structures at comparable companies like Honeywell International Inc. (HON) or Siemens AG (SIEGY), which also utilize equity awards to incentivize their non-executive directors.
  • The deferral option also aligns with common executive and director compensation plans designed for tax efficiency and long-term retention.

Stakeholder Impact

  • Shareholders: Positive impact through enhanced alignment of director interests with shareholder value creation.

Next Steps

  • No specific future actions or milestones are mentioned in this Form 4 filing.

Key Dates

DateDescription
10/01/2025Date of common stock grant to Director Timothy M. Leyden.
10/02/2025Date of filing signature by Christopher E. Ware, attorney-in-fact.

Keywords

Itron, ITRI, Timothy Leyden, Director Compensation, Stock Grant, Insider Transaction, Form 4, Equity Compensation, Deferred Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.